- The Clinical Outcome of FLAG Chemotherapy without Idarubicin in Patients with Relapsed or Refractory Acute Myeloid Leukemia
-
Lee SR, Yang DH, Ahn JS, Kim YK, Lee JJ, Choi YJ, Shin HJ, Chung JS, Cho YY, Chae YS, Kim JG, Sohn SK, Kim HJ
- KMID: 1779170
- J Korean Med Sci.
- 2009 Jun;24(3):498-503.
- doi: 10.3346/jkms.2009.24.3.498
A refractory and resistant disease to conventional induction chemotherapy and relapsed disease are considered as the most important adverse prognostic factors for acute myeloid leukemia (AML). Sixty-one patients (median age,... -
- CITED
-
- Close
- SHARE
-
- Close
